Daniel Rubin, PharmD, BCOP, discussed a study showing how a clinical decision support tool can improve the documentation of ...

By addressing inefficiencies before they occur and ensuring that every recommendation is backed by evidence-based research, IllumiCare is redefining how hospitals approach clinical waste.

In the deal, GenomOncology will integrate Pillar's RUO NGS panels into its clinical decision support platform to enable personalized cancer treatment insights.

The effectiveness of AI-powered CDSSs in clinical practice hinges on clinicians' trust and their willingness to rely on AI ...

Agentic AI in Healthcare Market OverviewThe global agentic AI in healthcare market is expected to grow at a rate of 35-40% ...

According to Intent Market Research, the Clinical Decision Support Systems Market is expected to grow from USD 1.9 billion in ...

GenomOncology, a precision medicine software company, and Pillar Biosciences, a leader in Decision Medicine™, today announced ...

Providers unknowingly prescribe expensive medications when equally effective and more affordable alternatives are available, order repetitive lab tests, and conduct duplicate imaging studies—all forms ...